Converthera Nad Plus Patch
NDC Package 85945-0001-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Converthera Nad Plus Patch patches is clean a dry, hair-free area (upper arm, abdomen, or back). This formulation utilizes a patch delivery system. Marketed by Through Medical Inc., this product is identified by NDC 85945-0001.

Identification & Billing

NDC Package Code
85945-0001-2
Package Description
8 U in 1 PATCH
Product Code
85945-0001
11-Digit Billing Format
85945000102

Clinical Specifications

Proprietary Name
Converthera Nad Plus Patch
Non-Proprietary Name
Converthera Nad Plus Patch
Substance Name
Glutathione; Nicotinamide Adenine Dinucleotide
Dosage Form
Patch - A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms ‘extended release film’ and ‘system’.
Administration Route
Transdermal - Administration through the dermal layer of the skin to the systemic circulation by diffusion.
Active Ingredient(s)
Usage Information
Clean a dry, hair-free area (upper arm, abdomen, or back). Add 8-10 drops of NAD+ solution to the patch. Apply the patch to skin firmly. Leave on for 4-6 hours, then remove and discard.

Regulatory & Marketing

Labeler Name
Through Medical Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
07-01-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (85945-0001). Click a package code to view its specific billing and regulatory data.

85945-0001-1
30 U in 1 PATCH

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85945-0001-2 identifies a specific commercial package of 8 u in 1 patch of Converthera Nad Plus Patch, a human over the counter drug labeled by Through Medical Inc.. This patch is formulated for transdermal use and contains glutathione; nicotinamide adenine dinucleotide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Through Medical Inc. on July 01, 2025. The current certification is valid through December 31, 2026.

How is this Through Medical Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85945000102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
85945-0001-2
11-Digit CMS (5-4-2)
85945-0001-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.